Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caleb Bliss

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 31, 2010
A brief motivational interview in a pediatric emergency department, plus 10-day telephone follow-up, increases attempts to quit drinking among youth and young adults who screen positive for problematic drinkingJudith Bernstein, Timothy Heeren, Erika Edward, et al.
European Child & Adolescent Psychiatry|July 22, 2020
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analysesDavid R Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 18, 2012
Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency departmentEdward Bernstein, Timothy Heeren, Michael Winter, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 2, 2018
Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorderMichael Huss, Keith McBurnett, Andrew J Cutler, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2016
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trialJennifer A Huntington, George Sakoulas, Obiamiwe Umeh, et al.
American Journal of Public Health|November 17, 2012
Predictors of active injection drug use in a cohort of patients infected with hepatitis C virusCarrie Reed, Caleb Bliss, Sherri O Stuver, et al.
AIDS Patient Care and Stds|February 12, 2011
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfectionShikha Garg, Melanie Hoenig, Erika M Edwards, et al.
Journal of Crohn'S & Colitis|December 14, 2023
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's DiseaseSéverine Vermeire, Silvio Danese, William J Sandborn, et al.
American Journal of Ophthalmology|February 15, 2025
Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks TrialUsha Chakravarthy, Roy Schwartz, Robyn H Guymer, et al.
American Journal of Ophthalmology|May 30, 2025
Erratum to "Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 OAKS Trial," [Am J Ophthalmol 2025; 273:119-129]Usha Chakravarthy, Roy Schwartz, Robyn H Guymer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 31, 2010
A brief motivational interview in a pediatric emergency department, plus 10-day telephone follow-up, increases attempts to quit drinking among youth and young adults who screen positive for problematic drinkingJudith Bernstein, Timothy Heeren, Erika Edward, et al.
European Child & Adolescent Psychiatry|July 22, 2020
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analysesDavid R Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 18, 2012
Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency departmentEdward Bernstein, Timothy Heeren, Michael Winter, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 2, 2018
Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorderMichael Huss, Keith McBurnett, Andrew J Cutler, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2016
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trialJennifer A Huntington, George Sakoulas, Obiamiwe Umeh, et al.
American Journal of Public Health|November 17, 2012
Predictors of active injection drug use in a cohort of patients infected with hepatitis C virusCarrie Reed, Caleb Bliss, Sherri O Stuver, et al.
AIDS Patient Care and Stds|February 12, 2011
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfectionShikha Garg, Melanie Hoenig, Erika M Edwards, et al.
Journal of Crohn'S & Colitis|December 14, 2023
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's DiseaseSéverine Vermeire, Silvio Danese, William J Sandborn, et al.
American Journal of Ophthalmology|February 15, 2025
Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks TrialUsha Chakravarthy, Roy Schwartz, Robyn H Guymer, et al.
American Journal of Ophthalmology|May 30, 2025
Erratum to "Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 OAKS Trial," [Am J Ophthalmol 2025; 273:119-129]Usha Chakravarthy, Roy Schwartz, Robyn H Guymer, et al.
Pageof 3